Atherectomy Devices Market Report 2026

Atherectomy Devices Market Overview

• Atherectomy Devices market size has reached to $1.01 billion in 2025 • Expected to grow to $1.54 billion in 2030 at a compound annual growth rate (CAGR) of 8.6% • Growth Driver: Rising Coronary Artery Disease Incidence Fuels Atherectomy Device Market Expansion • Market Trend: Innovative Atherectomy Peripheral Platform Catheters Shaping The Atherectomy Devices Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Atherectomy Devices Market?

Atherectomy devices are specialized medical instruments used in the procedure of atherectomy, a minimally invasive surgical technique to remove atherosclerotic plaque from blood vessels. Atherectomy devices are crucial in managing arterial blockages, offering a precise and minimally invasive solution to restore blood flow and alleviate symptoms associated with peripheral artery disease (PAD) and coronary artery disease (CAD). The main product types of atherectomy devices are rotational atherectomy devices, orbital atherectomy devices, directional atherectomy devices, and other products. Rotational atherectomy devices refer to specialized tools used to treat hardened, calcified plaques in arteries. The various applications are peripheral vascular applications, cardiovascular applications, and neurovascular applications. These are used by various end users including hospitals and surgical centers, ambulatory care centers, and others.

What Is The Atherectomy Devices Market Growth Forecast?

The atherectomy devices market size is expected to see strong growth in the next few years. It will grow to $1.54 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to rising demand for advanced plaque modification tools, increasing use of atherectomy in complex calcified lesions, growing investments in next-generation device design and materials, expansion of outpatient and ambulatory vascular procedures, increasing adoption of image-guided endovascular therapies. Major trends in the forecast period include increasing adoption of atherectomy devices as a minimally invasive alternative for plaque removal in pad and cad cases, rising demand for specialized atherectomy systems tailored for peripheral, coronary, and neurovascular interventions, growing clinical preference for precision plaque debulking to improve vessel patency and reduce restenosis risk, increasing utilization of atherectomy in combination with angioplasty and stenting for complex arterial lesions, expanding development of multi-technology atherectomy portfolios including rotational, orbital, directional, and laser systems.

What Is The Driver Of The Atherectomy Devices Market?

The prevalence of coronary artery disease is expected to propel the growth of the atherectomy devices market going forward. Coronary artery disease (CAD) refers to a condition characterized by the narrowing or blockage of the coronary arteries due to plaque buildup, leading to reduced blood flow to the heart. The prevalence of coronary artery disease is due to a global increase in the elderly population, a rise in sedentary behaviors, increased levels of stress and mental health issues, and increased consumption of unhealthy foods. Directional coronary atherectomy is a minimally invasive procedure designed to remove blockages from coronary arteries, enhancing blood flow to the heart muscle and alleviating pain. For instance, in May 2024, according to the Singapore Heart Foundation (SHF), a Singapore-based non-profit organization, the total number of deaths from cardiovascular disease rose to 8,311 in 2023, compared to 2022, while atherosclerosis-related deaths increased to 60% of all cardiovascular deaths in 2023, up from 59% in 2022.Therefore, the prevalence of coronary artery disease retailers is driving the growth of the atherectomy devices industry.

Key Players In The Global Atherectomy Devices Market

Major companies operating in the atherectomy devices market are Boston Scientific Corporation, Medtronic plc, Abbott Laboratories, Cardiovascular Systems Inc, Terumo Corporation, Avinger Inc, Straub Medical AG, AngioDynamics Inc, Rex Medical LP, Ra Medical Systems Inc, Koninklijke Philips NV, Shockwave Medical Inc, Merit Medical Systems Inc, iVascular SLU, Hawk Medical Technologies, Medinol Ltd, Cardionovum GmbH, Wellinq Medical Products, Veryan Medical, Penumbra Inc

Global Atherectomy Devices Market Trends and Insights

Major companies operating in the atherectomy devices market are developing innovative products, such as the atherectomy peripheral platform-based catheter, to gain a competitive edge in the market. An atherectomy peripheral platform-based catheter is a medical device utilized to treat peripheral artery disease by navigating through blood vessels to address arterial blockages in the legs. For instance, in October 2023, Cardio Flow, a US-based medical device company manufacturing, launched the FreedomFlow, an orbital atherectomy peripheral platform. The FreedomFlow platform employs a contemporary mechanism to remove plaque blockages in the leg arteries, utilizing a proprietary catheter-based design that utilizes angular momentum physics, featuring a spiral geometry with five diamond-coated spheres maintaining constant contact with the vessel wall during both advancement and retraction.

What Are Latest Mergers And Acquisitions In The Atherectomy Devices Market?

In April 2023, Abbott Laboratories, a US-based company manufacturing medical devices, acquired Cardiovascular Systems Inc. for an undisclosed amount. This acquisition strengthens Abbott's investment in its vascular portfolio, further enhancing its capacity to provide care for patients with peripheral and coronary artery disease. Cardiovascular Systems Inc. is a US-based medical device company involved in manufacturing innovative atherectomy systems.

What Defines the Atherectomy Devices Market?

The atherectomy devices market consists of sales of hydrodynamic atherectomy devices, laser atherectomy devices, and ultrasonic atherectomy devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Atherectomy Devices Market Report 2026?

The atherectomy devices market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the atherectomy devices industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.